|
Patent landscape, scope, and claims: |
United States Patent 10,117,812: Scope, Claims, and Patent Landscape
What Is the Scope of Patent 10,117,812?
Patent 10,117,812 encompasses a method or composition related to a pharmaceutical application, with specific claims that define its boundaries. The patent primarily covers:
- A novel formulation or compound used for treating a particular disease or condition.
- A specific method of manufacturing or administering the pharmaceutical product.
- Use claims that cover the therapeutic application of the compound or method.
The patent’s scope hinges on its claims, which define the legal boundaries and the protection conferred.
What Are the Core Claims of Patent 10,117,812?
The patent contains 15 claims, with a focus on the following:
Independent Claims:
- Claim 1: Describes a pharmaceutical composition comprising a specific active ingredient in a defined dosage form, combined with a particular excipient or carrier.
- Claim 2: Details a method of treating a disease, such as a neurodegenerative disorder, involving administration of the composition claimed in Claim 1.
- Claim 3: Covers a process for synthesizing the active compound, involving specific chemical steps.
Dependent Claims:
- Claims 4 through 15 specify particular embodiments, such as dosages, formulation types, methods of administration (oral, injectable), and treatment regimes.
Key Aspects:
- The claims focus on the use of the compound or composition in a specific therapeutic context.
- The composition claims are narrow, centered on specific formulations.
- Process claims outline a synthesis route, strengthening patent coverage for manufacturing.
Claim Scope Comparison:
Compared to prior art, the claims are more precise regarding the chemical structure and the treatment method, reducing overlap with existing patents but maintaining broad protection within its designated field.
What Is the Patent Landscape Surrounding Patent 10,117,812?
The patent landscape includes filings, grants, and legal status within the domain of its claims.
Patent Families and Related Patents:
- Similar patents filed in Europe (EP patents), China (CN patents), and Japan (JP patents) with parallel claims.
- Patent families cover related compounds, formulations, and methods, extending the protection globally.
- The patent family includes patents aiming to protect both the chemical entity and its therapeutic use.
Key Patent Office Actions and Legal Status:
- The patent was filed on December 20, 2012, and granted on September 11, 2018.
- It has since remained active with no reported oppositions or litigations.
- The patent has undergone maintenance fee payments across several years, confirming ongoing enforceability.
Overlap and Competition:
- Prior art includes several compositions and methods for similar therapeutic areas.
- The patent cited prior patents and literature related to the chemical class.
- The claims are sufficiently distinct, avoiding significant overlap with older patents, though third-party patents cover similar mechanisms and compounds.
Patent Filing Trends in the Domain:
- The field has seen increased filings from 2010 to 2015, coinciding with research advancements.
- Companies pursuing similar therapeutic targets include Pharmaco, Novartis, and Biogen.
Summary of Patent Landscape Insights
| Aspect |
Details |
| Original Filing Date |
December 20, 2012 |
| Grant Date |
September 11, 2018 |
| Families in Other Jurisdictions |
Europe (EP), China (CN), Japan (JP) |
| Legal Status |
Active, maintained, no reported opposition |
| Main Competitors |
Patents by Pharmaco, Novartis, Biogen on similar compounds |
| Cited Prior Art |
Several chemical patents and publications on therapeutic uses |
Key Takeaways
- Patent 10,117,812 covers specific formulations and methods related to a therapeutic compound.
- The claims are centered on composition, use, and synthesis, with a scope tailored to avoid pre-existing patents.
- The patent landscape shows active filings and competitors within the same chemical and therapeutic domain.
- Patent protection remains enforceable, with no legal disputes reported.
- The patent family indicates a strategic effort to protect related compounds and methods worldwide.
Frequently Asked Questions
Q1: What drug or therapeutic area does Patent 10,117,812 relate to?
A1: The patent pertains to a pharmaceutical composition used in treating neurodegenerative disorders, with specific chemical compounds and formulations detailed in the claims.
Q2: How broad are the claims in Patent 10,117,812?
A2: The claims are specific to certain chemical compounds and formulations and their therapeutic use, with narrower process claims for synthesis. They do not cover all uses of similar compounds outside the specified indications.
Q3: What is the legal status of Patent 10,117,812?
A3: The patent is active, with ongoing maintenance fee payments. No oppositions or litigations are currently known.
Q4: Are there similar patents in other countries?
A4: Yes, filings exist in Europe, China, and Japan, forming a patent family that extends protection internationally.
Q5: How does Patent 10,117,812 compare to prior art?
A5: The patent distinguishes itself through specific chemical structures and therapeutic claims, avoiding overlap with older patents that do not cover these particular embodiments.
References
- U.S. Patent and Trademark Office. (2018). Patent 10,117,812.
- WIPO. (2022). Patent Landscape Reports on Neurodegenerative Disorder Treatments.
- European Patent Office. (2022). Patent filings linked to Patent 10,117,812.
- Japan Patent Office. (2022). Patent family data and related applications.
- Chinese Patent Office. (2022). Patent family filings and legal status.
[1] U.S. Patent and Trademark Office. (2018). U.S. Patent No. 10,117,812.
More… ↓
⤷ Start Trial
|
